| Schedule of Investment in Common Shares and Market Value as Balance Sheet Dates |
The summary of the investment in NUAG common shares and its market value as at the respective reporting dates are as follows: | | | | | | | | | | | | | | | | Value of NUAG’s | | | | | | | | common shares per | | | Number of shares | | Amount | | quoted market price | As at April 1, 2024 | | 46,904,706 | | $ | 47,080 | | $ | 63,693 | Purchase from open market | | 2,995 | | | 4 | | | — | Share of net loss | | — | | | (1,188) | | | — | Share of other comprehensive loss | | — | | | (789) | | | — | Foreign exchange impact | | — | | | 169 | | | — | As at March 31, 2025 | | 46,907,701 | | $ | 45,276 | | $ | 51,598 | Participation in bought deal | | 3,083,536 | | | 7,807 | | | — | Purchase from open market | | 1,435,751 | | | 1,496 | | | — | Dilution loss | | — | | | (285) | | | — | Share of net loss | | — | | | (1,147) | | | — | Share of other comprehensive income | | — | | | 353 | | | — | As at March 31, 2026 | | 51,426,988 | | $ | 53,500 | | $ | 212,908 |
The summary of the investment in TIN common shares and its market value as at the respective reporting dates are as follows: | | | | | | | | | | | | | | | | | | Value of TIN’s common | | | | | | | | | shares per quoted | | | Number of shares | | Amount | | market price | As at April 1, 2024 | | | 19,864,285 | | $ | 2,346 | | $ | 2,346 | Share of net loss from TIN, net of impairment adjustments | | | — | | | (1,618) | | | — | Share of other comprehensive income | | | — | | | 5 | | | — | Foreign exchange impact | | | — | | | 7 | | | — | As at March 31, 2025 | | | 19,864,285 | | $ | 740 | | $ | 2,073 | Participation in private placement | | | 874,413 | | | 79 | | | — | Share of net income from TIN | | | — | | | 615 | | | — | Foreign exchange impact | | | — | | | (293) | | | — | As at March 31, 2026 | | $ | 20,738,698 | | $ | 1,141 | | $ | 7,439 |
|